These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 3898689

  • 1. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
    Thorén M, Adamson U, Sjöberg HE.
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
    [Abstract] [Full Text] [Related]

  • 2. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
    Child DF, Burke CW, Burley DM, Rees LH, Fraser TR.
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
    [Abstract] [Full Text] [Related]

  • 3. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA, Trainer PJ, Howlett TA, Perry L, Rees LH, Grossman AB, Wass JA, Besser GM.
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
    [Abstract] [Full Text] [Related]

  • 4. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M, Allolio B, Jaursch-Hancke C, Kaulen D, Winkelmann W.
    Dtsch Med Wochenschr; 1987 Oct 02; 112(40):1532-5. PubMed ID: 2820688
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
    Daniel E, Aylwin S, Mustafa O, Ball S, Munir A, Boelaert K, Chortis V, Cuthbertson DJ, Daousi C, Rajeev SP, Davis J, Cheer K, Drake W, Gunganah K, Grossman A, Gurnell M, Powlson AS, Karavitaki N, Huguet I, Kearney T, Mohit K, Meeran K, Hill N, Rees A, Lansdown AJ, Trainer PJ, Minder AE, Newell-Price J.
    J Clin Endocrinol Metab; 2015 Nov 02; 100(11):4146-54. PubMed ID: 26353009
    [Abstract] [Full Text] [Related]

  • 6. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D, Weber MM.
    J Steroid Biochem Mol Biol; 1994 Jun 02; 49(4-6):261-7. PubMed ID: 8043488
    [Abstract] [Full Text] [Related]

  • 7. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P, Droumaguet C, Salenave S, Blanchard A, Jublanc C, Gautier JF, Brailly-Tabard S, Leboulleux S, Schlumberger M, Baudin E, Chanson P, Young J.
    J Clin Endocrinol Metab; 2011 Sep 02; 96(9):2796-804. PubMed ID: 21752886
    [Abstract] [Full Text] [Related]

  • 8. [Cushing's syndrome. Medical treatment of adrenal hypercorticism].
    Bricaire H, Luton JP.
    Horm Res; 1980 Sep 02; 13(4-5):317-24. PubMed ID: 7274999
    [No Abstract] [Full Text] [Related]

  • 9. [Medical treatment for Cushing's syndrome].
    Nishikawa T, Saito J, Omura M.
    Nihon Rinsho; 2008 Jan 02; 66(1):186-91. PubMed ID: 18186263
    [Abstract] [Full Text] [Related]

  • 10. Aminoglutethimide: review of pharmacology and clinical use.
    Santen RJ, Misbin RI.
    Pharmacotherapy; 1981 Jan 02; 1(2):95-120. PubMed ID: 6765487
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Hunter PR, Ross W, Hall R, Cook DB.
    Proc R Soc Med; 1974 Dec 02; 67(12 Pt 1):1225. PubMed ID: 4375290
    [No Abstract] [Full Text] [Related]

  • 12. Medical treatment of Cushing's syndrome with aminoglutethimide and ketoconazole.
    Kong HL, Lee KO, Cheah JS.
    Singapore Med J; 1992 Oct 02; 33(5):523-4. PubMed ID: 1455284
    [Abstract] [Full Text] [Related]

  • 13. Results of treatment in 108 patients with Cushing's syndrome.
    Orth DN, Liddle GW.
    N Engl J Med; 1971 Jul 29; 285(5):243-7. PubMed ID: 4326256
    [No Abstract] [Full Text] [Related]

  • 14. Aminoglutethimide in the treatment of Cushing's syndrome.
    Misbin RI, Canary J, Willard D.
    J Clin Pharmacol; 1976 Jul 29; 16(11-12):645-51. PubMed ID: 993360
    [Abstract] [Full Text] [Related]

  • 15. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE.
    Expert Opin Emerg Drugs; 2009 Dec 29; 14(4):661-71. PubMed ID: 19939210
    [Abstract] [Full Text] [Related]

  • 16. Deoxycorticosterone and aldosterone excretion in Cushing's syndrome.
    Cassar J, Loizou S, Kelly WF, Mashiter K, Joplin GF.
    Metabolism; 1980 Feb 29; 29(2):115-9. PubMed ID: 7354720
    [Abstract] [Full Text] [Related]

  • 17. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
    Close CF, Mann MC, Watts JF, Taylor KG.
    Clin Endocrinol (Oxf); 1993 Sep 29; 39(3):375-9. PubMed ID: 8222300
    [Abstract] [Full Text] [Related]

  • 18. Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.
    Hána V, Dokoupilová M, Marek J, Plavka R.
    Clin Endocrinol (Oxf); 2001 Feb 29; 54(2):277-81. PubMed ID: 11207645
    [Abstract] [Full Text] [Related]

  • 19. Values for urinary free cortisol during treatment with amino-glutethimide for Cushing's syndrome.
    Schmitt KW, Juselius R, Hanlon J, Steed D.
    Clin Chem; 1973 Sep 29; 19(9):1067-8. PubMed ID: 4744809
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of major depression with steroid suppressive drugs.
    Murphy BE.
    J Steroid Biochem Mol Biol; 1991 Aug 29; 39(2):239-44. PubMed ID: 1888684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.